Asteroid Impact Carves 'Grand Canyons' on Moon in Just Minutes

Scientists across the United States are encountering significant disruptions to their research funding as a result of recent executive orders issued by former President Donald Trump. The National Science Foundation (NSF), which administers approximately $10 billion in annual research funding, experienced a shutdown of its payment gateway that left millions in federal grants on hold for five days. Although the gateway resumed operations on Sunday, concerns remain high regarding the future of funding amid new political scrutiny. Many researchers reported difficulties in processing funding requests and expressed alarm over potential changes impacting grants related to diversity, equity, and inclusion. According to a report by Nature, around 10,000 existing grants were flagged by NSF staff for possible cancellation. A California-based psychologist described the chilling effect these policies have on scholars' ability to voice political opinions, stating, "the administration is using unclear political criteria." As a result, researchers have begun forming private communication networks to safeguard academic freedom and exchange ideas to navigate these challenges, reflecting growing apprehension in the academic community.

President Donald Trump has enacted significant tariffs on Chinese goods, attributing the move to China's alleged failure to halt the export of chemicals used in fentanyl production. This comes as the U.S. grapples with a serious opioid crisis, with over 74,000 overdose deaths linked to fentanyl reported in 2023 by the U.S. Centers for Disease Control and Prevention. Trump has also criticized Canada and Mexico for not preventing smuggling activities but temporarily suspended tariffs against these nations following negotiations for enhanced border security. Fentanyl, a potent synthetic opioid, is primarily sourced from China, with its precursor chemicals trafficked through Mexico, where organizations such as the Sinaloa Cartel are heavily involved in production and distribution. According to U.S. Customs and Border Patrol, nearly all fentanyl seizures—approximately 4,500 lbs since September—occurred at the U.S.-Mexico border, while only 0.2% were intercepted at the Canadian border. Calls for accountability have intensified, with the Trump administration accusing Mexican authorities of colluding with drug cartels, a claim Mexico's President Claudia Sheinbaum dismissed as "slander." As the fentanyl supply chain expands, both U.S. and international efforts to curb its flood remain critically challenged.

The parents of Cole Schmidtknecht, a 22-year-old from Appleton, Wisconsin, have initiated a federal lawsuit against Walgreens and OptumRx, claiming negligence that contributed to their son's death from an asthma attack. According to the lawsuit, Schmidtknecht could not afford a life-saving inhaler priced at $539.19 after his insurance coverage was dropped. His parents argue that both companies failed to provide alternative options during his prescription refill request on January 10, 2024. Schmidtknecht had relied on his inhaler, Advair Diskus, since childhood but was left without it when it was excluded from OptumRx's formulary. His family contends that he was not given sufficient notice of this change, violating Wisconsin law. Five days after leaving the pharmacy without the inhaler, Schmidtknecht suffered a severe attack, leading to his death on January 21. The family seeks financial compensation and aims to spark reforms in the health care system, highlighting issues around pharmaceutical pricing and access to essential medications. Walgreens has not commented on the matter due to ongoing litigation, while OptumRx expressed sorrow over Schmidtknecht's death and stated they followed industry practices.